The US Food and Drug Administration (FDA) has granted another approval for Dupixent (dupilumab), for the treatment of adults ...

Earendil Labs, a US AI-driven R&D next-generation biologics therapeutics start-up, has entered into a license agreement with French pharma major Sanofi (Euronext: SAN) for two potential first-in-class ...

In keeping with US Department of Health and Human Services Secretary Robert F Kennedy Jr’s promise to carry out the ...

US President Donald Trump issued an executive order on April 15 listing several potential policy changes aimed at lowering US ...

Dutch gene therapy company uniQure (Nasdaq: QURE) announced that the US Food and Drug Administration (FDA) has granted ...

Australian clinical-stage biotech Neurizon Therapeutics (ASX: NUZ & NUZOA), which is advancing innovative treatments for ...

BigHat Biosciences, a Californian biotech with a machine learning (ML)-guided antibody discovery and development platform, ...

Orforglipron is the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water ...

Switzerland-based Addex Therapeutics, a biopharma developing a portfolio of novel small molecule allosteric modulators for ...

Advisory Committee on Immunization Practices (ACIP) has voted to expand its recommendation for the use of respiratory ...

Florida biopharma Ligand Pharmaceuticals subsidiary Pelthos Therapeutics is to merge with Channel Therapeutics (NYSE American ...

India’s Venus Remedies has secured Qualified Infectious Disease Product designation from the United States Food and Drug ...